In the battle between human antiretroviral drug therapy techniques and HIV-1 microevolution, HIV-1 is currently outpacing human antiretroviral drug therapy techniques: all treatments ultimately end in HIV-1 developing resistance to the treatment. Some scientists believe humans are pushing the microevolution of HIV-1 toward more resistant viruses. For example, some researchers claim that human drug therapies are accelerating retrovirus evolution through drug therapies that select for resistant viruses. Human intervention on HIV-1 evolution through drug therapies has also been accused of being detrimental to the ultimate goal of finding a permanent cure for HIV-1.
"synopsis" may belong to another edition of this title.
Dr. B. Babajan obtained his Ph.D., in Dept. of Biochemistry at Sri Krishnadevarya University. He is currently a Bioinformatic Scientist in PACER-HD at King Abdulaziz University, where he leads a group conducting research into Drug Discovery, SNP analysis, Genome Analysis and Computational Software's Development.
"About this title" may belong to another edition of this title.
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -In the battle between human antiretroviral drug therapy techniques and HIV-1 microevolution, HIV-1 is currently outpacing human antiretroviral drug therapy techniques: all treatments ultimately end in HIV-1 developing resistance to the treatment. Some scientists believe humans are pushing the microevolution of HIV-1 toward more resistant viruses. For example, some researchers claim that human drug therapies are accelerating retrovirus evolution through drug therapies that select for resistant viruses. Human intervention on HIV-1 evolution through drug therapies has also been accused of being detrimental to the ultimate goal of finding a permanent cure for HIV-1. 244 pp. Englisch. Seller Inventory # 9783659327537
Seller: moluna, Greven, Germany
Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: B. BabajanDr. B. Babajan obtained his Ph.D., in Dept. of Biochemistry at Sri Krishnadevarya University. He is currently a Bioinformatic Scientist in PACER-HD at King Abdulaziz University, where he leads a group conducting research in. Seller Inventory # 5148825
Seller: preigu, Osnabrück, Germany
Taschenbuch. Condition: Neu. Computational Drug Development Strategies to Target HIV-1 | A New Applications in Drug Discovery | Babajan B. (u. a.) | Taschenbuch | 244 S. | Englisch | 2013 | LAP LAMBERT Academic Publishing | EAN 9783659327537 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu. Seller Inventory # 106086973
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germany
Taschenbuch. Condition: Neu. This item is printed on demand - Print on Demand Titel. Neuware -In the battle between human antiretroviral drug therapy techniques and HIV-1 microevolution, HIV-1 is currently outpacing human antiretroviral drug therapy techniques: all treatments ultimately end in HIV-1 developing resistance to the treatment. Some scientists believe humans are pushing the microevolution of HIV-1 toward more resistant viruses. For example, some researchers claim that human drug therapies are accelerating retrovirus evolution through drug therapies that select for resistant viruses. Human intervention on HIV-1 evolution through drug therapies has also been accused of being detrimental to the ultimate goal of finding a permanent cure for HIV-1.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 244 pp. Englisch. Seller Inventory # 9783659327537
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - In the battle between human antiretroviral drug therapy techniques and HIV-1 microevolution, HIV-1 is currently outpacing human antiretroviral drug therapy techniques: all treatments ultimately end in HIV-1 developing resistance to the treatment. Some scientists believe humans are pushing the microevolution of HIV-1 toward more resistant viruses. For example, some researchers claim that human drug therapies are accelerating retrovirus evolution through drug therapies that select for resistant viruses. Human intervention on HIV-1 evolution through drug therapies has also been accused of being detrimental to the ultimate goal of finding a permanent cure for HIV-1. Seller Inventory # 9783659327537
Seller: Mispah books, Redhill, SURRE, United Kingdom
Paperback. Condition: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book. Seller Inventory # ERICA79636593275306
Quantity: 1 available